Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIF 1149 BS Safety and Pharmacodynamics in Healthy Males
NCT02199899Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 1999
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in cough comparing BIIF 1149 BS with Placebo (2 arms). Primary endpoint: Number of patients with adverse events at 4 months. Started Mar 1999; status: completed.
02
Drugs
figopitant
03
Conditions
cough
Beyond the preview
Go deeper on NCT02199899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199899.